New frontiers in the management of dyslipidaemia: Proprotein convertase subtilisin/kexin 9 inhibitors and small interfering ribonucleic acid

Affiliations

• ¹ BMed, MD, MMed, FRACGP, General Practitioner, Department of Primary Care, Macquarie University, NSW.
• ² MBBS, BMedSci (Hons), FRACGP, General Practitioner, Department of Primary Care, Macquarie University, NSW.
• ³ MBBS, PhD, FRACGP, General Practitioner, Professor, Department of Primary Care, Macquarie University, NSW.
• ⁴ MBBS (Hons), MPH, PhD, FRACGP, General Practitioner, Professor, Department of Primary Care, Macquarie University, Macquarie Park, NSW.